Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type

Galanthamine hydrobromide: Interim results of a group comparative, placebo-controlled study of efficacy and safety in patients with a diagnosis of senile dementia of the Alzheimer type

Bibliográfalaš dieđut
Váldodahkkit:	Wilcock, G, Wilkinson, D
Materiálatiipa:	Conference item
Almmustuhtton:	1997

Geahča maid

Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
Dahkki: Morar, C, et al.
Almmustuhtton: (1983)

GALANTHAMINE AND THE TREATMENT OF ALZHEIMERS-DISEASE
Dahkki: Wilcock, G, et al.
Almmustuhtton: (1993)

Tacrine for senile dementia of Alzheimer's or Lewy body type.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (1994)

The differential involvement of subcortical nuclei in senile dementia of Alzheimer's type.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (1988)

TETRAHYDROBIOPTERIN METABOLISM IN SENILE DEMENTIA OF ALZHEIMER TYPE
Dahkki: Jones, S, et al.
Almmustuhtton: (1987)

Cognitive decline in patients with Alzheimer's disease, vascular dementia and senile dementia of Lewy body type.
Dahkki: Ballard, C, et al.
Almmustuhtton: (1996)

Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
Dahkki: Appleyard, M, et al.
Almmustuhtton: (1987)

Senile Dementia from Neuroscientific and Islamic Perspectives
Dahkki: Tumiran, Mohd Amzari, et al.
Almmustuhtton: (2018)

Persistence of cholinergic neurons in the basal nucleus in a brain with senile dementia of the Alzheimer's type demonstrated by immunohistochemical staining for choline acetyltransferase.
Dahkki: Pearson, R, et al.
Almmustuhtton: (1983)

Design and development of galantamine hydrobromide transdermal patch for treatment of alzheimer’s disease
Dahkki: Woo, Fong Yen
Almmustuhtton: (2015)

Preparation of Arsenobetaine hydrobromide
Dahkki: Ismail, Hazar, et al.
Almmustuhtton: (1988)

Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type.
Dahkki: Jamieson, G, et al.
Almmustuhtton: (1992)

The crystal structure of diglycine hydrobromide
Dahkki: Barney, Elsa Pauline
Almmustuhtton: (2013)

The temporal lobe in dementia of Alzheimer's type.
Dahkki: Wilcock, G
Almmustuhtton: (1983)

Urban safety project : interim results for area wide schemes /
Dahkki: Ward, Heather A., et al.
Almmustuhtton: (1988)

Pathologic diagnosis of Alzheimer's.
Dahkki: Köster, R, et al.
Almmustuhtton: (1989)

Lewy body dementia--diagnosis and treatment.
Dahkki: McKeith, I, et al.
Almmustuhtton: (1995)

Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease: multicenter trial.
Dahkki: Pirttilä, T, et al.
Almmustuhtton: (2004)

An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (1993)

The diagnosis of vascular dementia in the light of the new criteria.
Dahkki: Amar, K, et al.
Almmustuhtton: (1996)

Functional dopamine deficits in the senile rat retina.
Dahkki: Hankins, M
Almmustuhtton: (2000)

Senile parkinsonism, a study of current treatment.
Dahkki: White, N, et al.
Almmustuhtton: (1981)

Dopamine pathways are selectively affected in the senile retina.
Dahkki: Hankins, M
Almmustuhtton: (2000)

Blood pressure, dementia and Alzheimer's disease: the OPTIMA longitudinal study.
Dahkki: Razay, G, et al.
Almmustuhtton: (2009)

Lipase-catalysed synthesis of a novel galanthamine derivative: process optimisation by artificial neural networks
Dahkki: Ashari, Siti Efliza, et al.
Almmustuhtton: (2020)

In vivo localization of human acetylcholinesterase-derived species in a β-sheet conformation at the core of senile plaques in Alzheimer's disease
Dahkki: Jean, L, et al.
Almmustuhtton: (2019)

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (2008)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial. Galantamine International-1 Study Group.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (2000)

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
Dahkki: Hansen, L, et al.
Almmustuhtton: (1998)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: Results of a double-blind, randomised placebo-controlled trial
Dahkki: Reginster, J, et al.
Almmustuhtton: (2012)

Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial.
Dahkki: Reginster, J, et al.
Almmustuhtton: (2013)

Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: multicentre randomised controlled trial (vol 321, pg 1445, 2000)
Dahkki: Wilcock, G
Almmustuhtton: (2001)

New insights into the genetic etiology of Alzheimer’s disease and related dementias
Dahkki: Bellenguez, C, et al.
Almmustuhtton: (2022)

Donepezil for dementia due to Alzheimer's disease
Dahkki: Birks, J, et al.
Almmustuhtton: (2018)

The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type.
Dahkki: Amar, K, et al.
Almmustuhtton: (1996)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
Dahkki: Wilcock, G, et al.
Almmustuhtton: (1982)

Association of hippocampal volume with gait variability in pre-dementia and dementia stages of Alzheimer disease : results from a cross-sectional study
Dahkki: Beauchet, Olivier, et al.
Almmustuhtton: (2020)

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
Dahkki: Wilcock, G, et al.
Almmustuhtton: (2002)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9) (1445-1449))
Dahkki: Wilcock, G
Almmustuhtton: (2001)

Erratum: Efficacy and safety of galantamine in patients with mild to moderate Alzheimer's disease: Multicentre randomised controlled trial (British Medical Journal (December 9)(1445-1449))
Dahkki: Wilcock, G
Almmustuhtton: (2001)